Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05653843 · ClinicalTrials.gov registry record
MANTIS Endoscopic Clipping Study
A clinical trial of Endoscopy and Hemostasis, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 240
- Enrollment target
- 10
- Study locations
NCT05653843: Completed study of Endoscopy and Hemostasis, sponsored by Boston Scientific Corporation.
NCT05653843 is a study of Endoscopy and Hemostasis that has completed, run by Boston Scientific Corporation. The registered enrollment target is 240 participants, above the 212-participant average among 7 other Endoscopy trials with a reported enrollment target (13% higher). The trial reports 10 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05653843, a study of Endoscopy and Hemostasis, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study is intended to document procedural and clinical effectiveness in consecutive cases in which at least one MANTIS clip is selected, pertaining to use of a new endoscopic clipping device MANTIS™ including but not limited to hemostasis, closure, anchoring and marking.
Primary Outcome
Clinical success defined as hemostasis of an active bleeding assessed at the time of the index clipping procedure
Conditions Studied
Interventions
- DEVICE Endoscopic clip placement in the gastrointestinal tract.
Study Locations (10)
Indiana
- Indiana University Medical Center - Indianapolis
Massachusetts
- Brigham and Women's Hospital - Boston
New Hampshire
- Dartmouth Hitchcock Medical Center - Lebanon
New York
- Icahn School of Medicine at Mount Sinai - New York
Onterio
- St Michael's Hospital - Toronto
Quebec
- Centre Hospitalier de l'Université de Montréal (CHUM) - Montreal
Xuhui District
- Shanghai Zhongshan Hospital - Shanghai
Shatin
- Prince of Wales Hospital The Chinese University of Hong Kong - Hong Kong
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-03-28 |
| Est. Completion | 2024-08-07 |
What the finished NCT05653843 record still lists
NCT05653843 is an observational study that tracks outcomes without assigning an intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, above the 212-participant average among 7 other Endoscopy trials with a reported enrollment target (13% higher).
The record links to 4 conditions, with Endoscopy appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic clip placement in the gastrointestinal tract. is the first listed.
NCT05653843 lists 10 locations in 10 states (Indiana, Massachusetts, New Hampshire).
Frequently Asked Questions
What is clinical trial NCT05653843 about?
NCT05653843 is a clinical study titled "MANTIS Endoscopic Clipping Study". This study is intended to document procedural and clinical effectiveness in consecutive cases in which at least one MANTIS clip is selected, pertaining to use of a new endoscopic clipping device MANTIS™ including but not limited to hemostasis, closure, anchoring and marking.
What is the current status of trial NCT05653843?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2023-03-28. Estimated completion is 2024-08-07.
What conditions does trial NCT05653843 study?
This clinical trial studies the following conditions: Endoscopy, Hemostasis, Perforation Colon, Feeding Tube Complication.
What interventions are being tested in trial NCT05653843?
The interventions under investigation include: Endoscopic clip placement in the gastrointestinal tract. (DEVICE).
Who is sponsoring clinical trial NCT05653843?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05653843 being conducted?
This trial has 10 study locations across Indiana, Massachusetts, New Hampshire, New York, Onterio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endoscopy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Can Nitrous Oxide (Laughing Gas) be Used as a Sedative for GI Endoscopy Procedures?
RECRUITING · Phase 4
-
Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration
RECRUITING · Phase 3
-
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
COMPLETED · NA
-
Is End Tidal CO2 Level Elevation During Upper Endoscopy With CO2 Gas Insufflation Physiologically Significant
COMPLETED · NA
-
Doppler Ultrasound Probe for Blood Flow Detection in Severe Upper Gastrointestinal Hemorrhage
COMPLETED · NA
-
A Safety Study of 3 Different Bowel Cleansing Preparations
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI